The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis
Objective: To compare the therapeutic efficacies of high dose dexamethasone, prednisone and rituximab in combination with dexamethasone for newly diagnosed ITP (Immune Thrombocytopenia, ITP) patients.Methods and results: Relevant publications for this study were obtained by searching PubMed, Embase,...
Main Authors: | Qirong Xiao, Bicun Lin, Hanyu Wang, Weiwu Zhan, Ping Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.656792/full |
Similar Items
-
Altas dosis de dexametasona en la trombocitopenia inmune primaria crónica High-dose dexamethasone in chronic primary immune thrombocytopenia
by: Wilfredo Roque-García, et al.
Published: (2012-12-01) -
Distinct alterations of CD68+CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
by: Xia Shao, et al.
Published: (2018-03-01) -
Efficacy of Dexamethasone for Acute Primary Immune Thrombocytopenia Compared to Prednisolone: A Systematic Review and Meta-analysis
by: Yasuyuki Arai, et al.
Published: (2017-07-01) -
Rituximab treatment efficacy in a patient with systemic lupus erythematosus with severe thrombocytopenia
by: Alexandrova O.L., et al.
Published: (2018-09-01) -
Evaluation of treatment plan by three-period pulses of high-dose dexamethasone among patients with primary immune thrombocytopenia on platelet count response and adverse events: A randomized Clinical trial
by: Alireza Sadeghi, et al.
Published: (2020-01-01)